WCM
AURA icon

WealthTrak Capital Management’s Aura Biosciences AURA Stock Holding History

WealthTrak Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15
Closed -$124 – 985
2024
Q4 		$124 Buy
+15
New +$141 ﹤0.01% 877

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

WealthTrak Capital Management's AURA Position: Q1 2025 in Review

WealthTrak Capital Management sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 15 shares — an estimated $124 sold.

WealthTrak Capital Management first reported a position in AURA in Q4 2024 and held it in 1 quarter. The position peaked at $124 in Q4 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

  • WealthTrak Capital Management reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 15 Aura Biosciences shares in Q1 2025, an estimated $124.
  • WealthTrak Capital Management first reported a position in Aura Biosciences in Q4 2024 and held it in 1 quarter.
  • WealthTrak Capital Management's Aura Biosciences position peaked at $124 in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on WealthTrak Capital Management's 13F filing for Q1 2025, filed 15 May 2025.